LS
Insider
Laura Lee Sandler
Chief Operating OfficerLaura Lee Sandler (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $424K of ORKA (4,500 sh across 2 lots, as filed), executed Jul 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Sep 1
Filed Sep 1
Median ADV $139.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ORKARecent filings
ORKASALE
Oruka Therapeutics, Inc.
View filing →
$368K4,000 sh × $92.01
Exec Sep 1
Filed Sep 1 · 6:36 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $424K
4,500 sh across 2 lots
Exec Jul 1
Filed Jul 1 · 7:58 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $253K
4,000 sh across 2 lots
Exec May 1
Filed May 1 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $246K
8,748 sh × $28.17
Exec Jan 2
Filed Jan 2 · 5:30 PM ET